Abiopharma

🔍 Andrews Brian G (Executive)

Company: COOPER COMPANIES, INC. (COO)

Report Date: 2025-09-02

Detailed Transactions and Holdings:

• Acquired 1,525 shares of Common Stock at $65.68 per share (Direct)
  Date: 2025-09-02 | Code: P | equity_swap_involved: false | shares_owned_after: 22,191.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-09-02 | Code: H | shares_owned_after: 6,902.00 | Footnotes: F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $65.25 to $65.97, inclusive. The reporting person undertakes to provide Cooper Companies, Inc., any security holder of Cooper Companies, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
• F2: Reflects 8,293 directly held shares transferred to Andrews Family Trust on 2/18/2025.
• F3: Shares held by Andrews Family Trust, of which the Reporting Person and his spouse are co-trustees.
• F4: Includes 288 shares acquired under the Issuer's ESPP: 103 on 2/1/2025 and 185 on 5/1/2025.